Andrew Atz to Immunoglobulins, Intravenous
This is a "connection" page, showing publications Andrew Atz has written about Immunoglobulins, Intravenous.
Connection Strength
0.106
-
Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011 May; 158(5):831-835.e3.
Score: 0.089
-
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007 Feb 15; 356(7):663-75.
Score: 0.017